Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06444165
Status:
COMPLETED
Last Update Posted:
2024-07-10
First Post:
2024-05-31
Brief Title:
Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis
Sponsor:
Organization:
Eli Lilly and Company